Cargando…
Patients presenting with stage IV uveal melanoma: Lessons learned
Challenges persist in identifying patients with stage IV uveal melanoma. While clinical, histopathologic, and genetic features of the primary tumor have been shown to provide prognostic value for assessing metastatic risk, biopsy-related genetic analyses are expensive and not universally available....
Autores principales: | Garg, Gaurav, Kivelä, Tero T, Finger, Paul T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917521/ https://www.ncbi.nlm.nih.gov/pubmed/34937253 http://dx.doi.org/10.4103/ijo.IJO_1478_21 |
Ejemplares similares
-
Patients presenting with metastases: stage IV uveal melanoma, an international study
por: Garg, Gaurav, et al.
Publicado: (2022) -
Impact of staging on survival outcomes: a nationwide real-world cohort study of metastatic uveal melanoma
por: Rantala, Elina S., et al.
Publicado: (2021) -
Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis
por: Rantala, Elina S., et al.
Publicado: (2019) -
Occult anterior uveal melanomas presenting as extrascleral extension
por: Maheshwari, Abhilasha, et al.
Publicado: (2023) -
Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer
por: Piperno-Neumann, Sophie, et al.
Publicado: (2019)